Analytical Quality by Design with the Lifecycle Approach: A Modern Epitome for Analytical Method Development

Alhakeem, Maher Abdulrazzaq; Ghica, Mihaela Violeta; Pîrvu, Cristina Dinu; Anuța, Valentina; Popa, Lăcrămioara

doi:10.2478/amma-2019-0010

References

1. ICH Expert Working Group. International Conference on Harmonization (ICH), Tripartite guidelines, ICHQ8(R2): Pharmaceutical Development. 2009. London.
Search in Google Scholar Back to article
2. Zlota, “Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing, “Three-day course presented at ZLOTA Company LLC in conjunction with Scientific Update LLP, http://www.scientificupdate.co.uk/training/scheduledtraining-courses/details/216-actical%20Approaches%20to%20Quality%20by%20Design%20for%20Pharmaceutical%20Process%20R.html’DandManufacturing.
Search in Google Scholar Back to article
3. Phil JB, John R, Chris J, Melissa HB, Roman S, Simon B. The development phase of an LC method using QbD principles. Journal of Separation Science.2010; 2: 2–8.
Search in Google Scholar Back to article
4. Monika LJ, Santosh RT. Implementation of QbD approach to the analytical method development and validation for the estimation of propafenone hydrochloride in tablet dosage form. Chromatography Research International. 2013; 2013:1-9.10.1155/2013/676501
Search in Google Scholar Back to article
5. Ferreira AP, Gamble JF, Leane MM, Park H, Olusanmi D, Tobyn M. Enhanced Understanding of Pharmaceutical Materials Through Advanced Characterisation and Analysis. AAPS PharmSciTech. 2018;19(8):3462-3480.10.1208/s12249-018-1198-630411240
Search in Google Scholar Back to article
6. Taevernier L, Wynendaele E, D Hondt M, De Spiegeleer B. Analytical quality-by-design approach for sample treatment BSA-containing solutions. Journal of Pharmaceutical Analysis. 2015;5(1):27–32.10.1016/j.jpha.2014.06.001576146829403912
Search in Google Scholar Back to article
7. USP Validation and verification expert panel. Proposed New USP General Chapter: The Analytical Procedure Lifecycle 〈1220〉. United State Pharmacopeial Convention (USP). Pharmacopeial forum. 2017;43 (1).
Search in Google Scholar Back to article
8. Zhang L, Shirui M. Application of quality by design in the current drug development. Asian Journal of Pharmaceutical Sciences.2017;12:1–8.10.1016/j.ajps.2016.07.006703218332104308
Search in Google Scholar Back to article
9. Pallagi E, Ambrus R, Szabó-Révész P, Csóka I. Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation. Int J Pharm. 2015;491(1-2):384-92.10.1016/j.ijpharm.2015.06.01826134895
Search in Google Scholar Back to article
10. Peraman R, Bhadraya K, Padmanabha RY. Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics. International Journal of Analytical Chemistry.2015; 2015:1-9.10.1155/2015/868727433298625722723
Search in Google Scholar Back to article
11. Rohin M, Anurag SR. quality by design: an overview of the basic concepts, quality by design for biopharmaceuticals. John Wiley & Sons, Inc., Publication. Hoboken, NJ, 2009,1-20.10.1002/9780470466315.ch1
Search in Google Scholar Back to article
12. Phil N, Phil JB, Tony B, Greg M, Pauline M. QbD for Better Method Validation and Transfer. http://www.pharmamanufacturing.com/articles/2010/060.html. 2010.
Search in Google Scholar Back to article
13. George LR, Guilong C, David TF et al. Reversed-phase liquid chromatographic method development in an analytical quality by design framework. Journal of Liquid Chromatography and Related Technologies. 2013; 36(18): 2612–2638.10.1080/10826076.2013.765457
Search in Google Scholar Back to article
14. Bhusnure OG, Gandge NV, Gholve SB. Sugave BK, Giram PS. A Review on Application of Quality by Design Concept to Analytical Method Development. Ijppr.Human, 2017; Vol. 10 (1): 63-75.
Search in Google Scholar Back to article
15. USP Validation and verification expert panel. Lifecycle management of analytical procedures: method development, procedure performance qualification, and procedure performance verification. United State Pharmacopeial Convention (USP). Pharmacopeial Forum.2013; 39(5).
Search in Google Scholar Back to article
16. Vogt FG, Kord AS. Development of quality-by-design analytical methods. J Pharm Sci. 2011; 100:797-812.10.1002/jps.2232521280050
Search in Google Scholar Back to article
17. Lynn DT. OOS, OOT, OOC, and OOSC. Pharmaceutical Technology. 2011; 35(10):46–47.
Search in Google Scholar Back to article
18. N. V. V. S. S. Raman, Useni RM, Hanimi RB.Analytical Quality by Design Approach to Test Method Development and Validation in Drug Substance Manufacturing. Journal of Chemistry. 2015; 2015:1-8.10.1155/2015/435129
Search in Google Scholar Back to article
19. Mayank N, Panwar KS, Chopra VS, Indu B, Trivedi P. Quality by design: a systematic approach to pharmaceutical development. Der Pharmacia Lettre. 2010; 2:111-3.
Search in Google Scholar Back to article
20. ICH. Q8 (R2) Pharmaceutical development. 2009. http://www.ich.org/fileadmin/PublicWebSite/ICHProducts/Guidelines/Quality/Q8R1/Step4/Q8R2Guideline.pdf. Accessed 26 April 2013.
Search in Google Scholar Back to article
21. Bettencourt DS., Bulska E, Godlewska-Żyłkiewicz B, et al. Analytical measurement: measurement uncertainty and statistics, European Commission -Joint Research Centre, Luxembourg, Publications Office of the European Union,2013: 19-85.
Search in Google Scholar Back to article
22. USP Validation and verification expert panel. Analytical target profile: Structure and Application throughout the analytical lifecycle. United State Pharmacopeial Convention (USP). Pharmacopeial Forum.2016; 42 (5).
Search in Google Scholar Back to article
23. USP Validation and verification expert panel. Measurement Uncertainty for the Pharmaceutical Industry. Pharmacopeial Forum. 2018; 44(1).
Search in Google Scholar Back to article
24. Quality Risk Management Q9, ICH Harmonised Tripartite Guideline, 2005.
Search in Google Scholar Back to article
25. David V, Miroslav K. selected overview of risk assessment techniques, Problemy eksploatacji. 2009:19-32.
Search in Google Scholar Back to article
26. Balaji J, Murugesh S. Analytical Quality by Design – A Legitimate Paradigm for Pharmaceutical Analytical Method Development and Validation. Mechanics, Materials Science & Engineering. 2017;9. Doi 10.2412/mmse.96.97.27610.2412/mmse.96.97.276
Open DOI Search in Google Scholar Back to article
27. Varanasi UB, B. D. C. N. Prasad. A Framework for Auditing the Evaluation of Uncertainty for Compliance in Information Systems. Lecture Notes on Software Engineering.2015; 3(1).10.7763/LNSE.2015.V3.162
Search in Google Scholar Back to article
28. Deviation Handling and Quality Risk Management, World Health Organization (WHO), A note for guidance for the manufacture of prequalified vaccines for supply to United Nations agencies Geneva, Switzerland, July 2013.
Search in Google Scholar Back to article
29. U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry.July 2015.
Search in Google Scholar Back to article
30. Mogal V, Dusane J, Borase P, Thakare P, Kshirsagar S. A review on quality by design, Mogal V. et al. Pharmaceutical and Biological Evaluations 2016; vol. 3 (3): 313-319.
Search in Google Scholar Back to article
31. Meitz A, Sagmeister P, Langemann T, Herwig C. An Integrated Downstream Process Development Strategy along QbD Principles, Bioengineering 2014; 1, 213-230.10.3390/bioengineering104021328955025
Search in Google Scholar Back to article
32. Kochling J, Wu W, Hua Y, Guan Q, Castaneda-Merced J. A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis. J Pharm Biomed Anal. 2016; 125:130-9.10.1016/j.jpba.2016.03.03127017571
Search in Google Scholar Back to article
33. Priyanka PP, Sadikali FS, Machindra JC, Sanjay RC. Quality by design in analytical method development and validation. Journal of Environment and Life Science.2017;2:39-45.
Search in Google Scholar Back to article
34. M. Deepa, K. Ravindra Reddy, S. V. Satyanarayana. A Review on Quality by Design Approach for Analytical Method Development. Journal of Pharmacy Research 2017;11(4):272-277.
Search in Google Scholar Back to article
35. U.S. Food and Drug Administration CDER. Guidance for industry: PAT—a framework for innovative pharmaceutical development, manufacturing, and quality assurance. 2004.
Search in Google Scholar Back to article
36. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding Pharmaceutical Quality by Design. AAPS J.2014;16(4): 771–783.10.1208/s12248-014-9598-3407026224854893
Search in Google Scholar Back to article
37. USP Validation and verification expert panel. Analytical Control Strategy. United State Pharmacopeial Convention (USP). Pharmacopeial Forum.2016; 42(5).
Search in Google Scholar Back to article
38. Quality assurance of pharmaceuticals: a compendium of guidelines and related materials. Vol. 2, Good manufacturing practices and inspection. – 2nd ed.
Search in Google Scholar Back to article
39. Le Blond D., Weitzel J., Burdick R. Analytical Quality by Design Approach to the Development Stage in the Lifecycle of an Analytical Procedure. web’ Institute of Validation Technology, IVT Network. 2017
Search in Google Scholar Back to article
40. Karmarkar S, Garber R, Genchanok Y, George S, Yang X, Hammond R. Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. J Chromatogr. Sci.2011;49(6):439-46.10.1093/chrsci/49.6.439
Search in Google Scholar Back to article